<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-30T03:25:33Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/9924" metadataPrefix="etdms">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/9924</identifier><datestamp>2025-01-16T01:05:34Z</datestamp><setSpec>com_10259_4862</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_4863</setSpec></header><metadata><thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.0/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>PKN1 Kinase: A Key Player in Adipocyte Differentiation and Glucose Metabolism</title>
<creator>Herrerías-González, Fernando</creator>
<creator>Yeramian, Andrée</creator>
<creator>Baena-Fustegueras, Juan Antonio</creator>
<creator>Bueno, Marta</creator>
<creator>Fleitas, Catherine</creator>
<creator>de la Fuente, Maricruz</creator>
<creator>Serrano, José C. E.</creator>
<creator>Granado-Serrano, Ana</creator>
<creator>Santamaría, Maite</creator>
<creator>Yeramian Hakim, Nadine</creator>
<creator>Zorzano-Martínez, Marta</creator>
<creator>Mora, Conchi</creator>
<creator>Lecube, Albert</creator>
<subject>PKN1</subject>
<subject>Visceral adipose tissue</subject>
<subject>Insulin resistance</subject>
<subject>Type 2 diabetes</subject>
<subject>Adipocyte</subject>
<subject>Glucose metabolism</subject>
<description>Adipocyte dysfunction is the driver of obesity and correlates with insulin resistance and the&#xd;
onset of type 2 diabetes. Protein kinase N1 (PKN1) is a serine/threonine kinase that has been shown&#xd;
to contribute to Glut4 translocation to the membrane and glucose transport. Here, we evaluated the&#xd;
role of PKN1 in glucose metabolism under insulin-resistant conditions in primary visceral adipose&#xd;
tissue (VAT) from 31 patients with obesity and in murine 3T3-L1 adipocytes. In addition, in vitro&#xd;
studies in human VAT samples and mouse adipocytes were conducted to investigate the role of&#xd;
PKN1 in the adipogenic maturation process and glucose homeostasis control. We show that insulinresistant adipocytes present a decrease in PKN1 activation levels compared to nondiabetic control&#xd;
counterparts. We further show that PKN1 controls the adipogenesis process and glucose metabolism.&#xd;
PKN1-silenced adipocytes present a decrease in both differentiation process and glucose uptake,&#xd;
with a concomitant decrease in the expression levels of adipogenic markers, such as PPARγ, FABP4,&#xd;
adiponectin and CEBPα. Altogether, these results point to PKN1 as a regulator of key signaling&#xd;
pathways involved in adipocyte differentiation and as an emerging player of adipocyte insulin&#xd;
responsiveness. These findings may provide new therapeutic approaches for the management of&#xd;
insulin resistance in type 2 diabetes.</description>
<date>2025-01-15</date>
<date>2025-01-15</date>
<date>2023-05</date>
<type>info:eu-repo/semantics/article</type>
<identifier>http://hdl.handle.net/10259/9924</identifier>
<identifier>10.3390/nu15102414</identifier>
<identifier>2072-6643</identifier>
<language>spa</language>
<relation>Nutrients. V. 15, n. 10, p. 2414</relation>
<relation>https://doi.org/10.3390/nu15102414</relation>
<rights>http://creativecommons.org/licenses/by/4.0/</rights>
<rights>info:eu-repo/semantics/openAccess</rights>
<rights>Atribución 4.0 Internacional</rights>
<publisher>MDPI</publisher>
</thesis></metadata></record></GetRecord></OAI-PMH>